Abstract:It is notorious that cancer cells alter their metabolism to adjust to harsh environments of hypoxia and nutritional starvation. Metabolic reprogramming most often occurs in the tumor microenvironment (TME). TME is defined as the cellular environment in which the tumor resides. This includes surrounding blood vessels, fibroblasts, immune cells, signaling molecules and the extracellular matrix (ECM). It is increasingly recognized that cancer cells, fibroblasts and immune cells within TME can regulate tumor progression through metabolic reprogramming. As the most significant proportion of cells among all the stromal cells that constitute TME, cancer-associated fibroblasts (CAFs) are closely associated with tumorigenesis and progression. Multitudinous studies have shown that CAFs participate in and promote tumor metabolic reprogramming and exert regulatory effects via the dysregulation of metabolic pathways. Previous studies have demonstrated that curbing the substance exchange between CAFs and tumor cells can dramatically restrain tumor growth. Emerging studies suggest that CAFs within the TME have emerged as important determinants of metabolic reprogramming. Metabolic reprogramming also occurs in the metabolic pattern of immune cells. In the meanwhile, immune cell phenotype and functions are metabolically regulated. Notably, immune cell functions influenced by metabolic programs may ultimately lead to alterations in tumor immunity. Despite the fact that multiple previous researches have been devoted to studying the interplays between different cells in the tumor microenvironment, the complicated relationship between CAFs and immune cells and implications of metabolic reprogramming remains unknown and requires further investigation. In this review, we discuss our current comprehension of metabolic reprogramming of CAFs and immune cells (mainly glucose, amino acid, and lipid metabolism) and crosstalk between them that induces immune responses, and we also highlight their contributions to tumorigenesis and progression. Furthermore, we underscore potential therapeutic opportunities arising from metabolism dysregulation and metabolic crosstalk, focusing on strategies targeting CAFs and immune cell metabolic crosstalk in cancer immunotherapy.

Metabolic crosstalk in the breast cancer microenvironment

The Emerging Roles of Metabolism in the Crosstalk Between Breast Cancer Cells and Tumor-Associated Macrophages

The metabolic crosstalk of cancer-associated fibroblasts and tumor cells: Recent advances and future perspectives

Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy

Metabolic Interplay in the Tumor Microenvironment: Implications for Immune Function and Anticancer Response

Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment

Editorial: Tumor microenvironment and metabolic reprogramming in cancer

The Neglected Liaison: Targeting Cancer Cell Metabolic Reprogramming Modifies the Composition of Non-Malignant Populations of the Tumor Microenvironment

Altered metabolism in cancer: insights into energy pathways and therapeutic targets

Metabolic Reprogramming in Cancer: Implications for Immunosuppressive Microenvironment

The Metabolism Symbiosis Between Pancreatic Cancer and Tumor Microenvironment

Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications

Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution

Metabolic communication in the tumour–immune microenvironment

Reprogramming of Lipid Metabolism Mediates Crosstalk, Remodeling, and Intervention of Microenvironment Components in Breast Cancer

Redox and metabolic reprogramming in breast cancer and cancer-associated adipose tissue

Computational dissection of the regulatory mechanisms of aberrant metabolism in remodeling the microenvironment of breast cancer

Contribution of adipocytes in the tumor microenvironment to breast cancer metabolism

Targeting Tumor Microenvironment for Cancer Therapy

Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism

A new perspective on the therapeutic potential of tumor metastasis: targeting the metabolic interactions between TAMs and tumor cells